(Reuters) - The Food and Drug Administration will make the final
decision but usually follows panel recommendations.
Lilly already sells Evista now for treatment and prevention
of osteoporosis in women past menopause.
Read more at Reuters.com Government Filings News
decision but usually follows panel recommendations.
Lilly already sells Evista now for treatment and prevention
of osteoporosis in women past menopause.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment